1003-3734
2012 Issue 3
Preparation and quality control of oral colon-targeting capsules of low molecular weight heparin
LIN Ang;WANG Ke;MA Ming-yi;LI Han;Lü Zhong-chao;LUO Jun-yong;CUI Hui-fei
LIN Ang;WANG Ke;MA Ming-yi;LI Han;Lü Zhong-chao;LUO Jun-yong;CUI Hui-fei
..............page:315-317,331
Progress in research of the targets for inotropic agents
XU Yi1;LUO Zhuo-ka1;HUANG Fei-fei1;LI Xue-hua1;CHEN Long1;2
XU Yi1;LUO Zhuo-ka1;HUANG Fei-fei1;LI Xue-hua1;CHEN Long1;2
..............page:268-272
..............page:218
Biotransformation of triptolide to (5R)-5-hydroxytriptolide
ZHAO Shun-bo1;2;HUANG Hai-hua2;CHEN Xiao-yan2;LI Xiu-li2;ZHONG Da-fang1;2
ZHAO Shun-bo1;2;HUANG Hai-hua2;CHEN Xiao-yan2;LI Xiu-li2;ZHONG Da-fang1;2
..............page:303-309
Preparation and release test of nicotinic acid sustained-release pellets
CHEN Jin-tuo;YIN Li-fang;ZHOU Jian-ping
CHEN Jin-tuo;YIN Li-fang;ZHOU Jian-ping
..............page:246-250
Inhibitory effect of polypeptide extracts from scorpion venom on proliferation of ovarian cancer SKOV3 cells
SONG Xiu-yun;WANG Zhao-peng;JIA Qing;WANG Zhao-xia;NING Yun-na; SUN Xiao-jia;WANG Xiao-hui;ZHANG Wei-dong
SONG Xiu-yun;WANG Zhao-peng;JIA Qing;WANG Zhao-xia;NING Yun-na; SUN Xiao-jia;WANG Xiao-hui;ZHANG Wei-dong
..............page:257-261
Some consideration about how to provide experimental evidence in pharmaceutical patent applications
CHEN Hong-xia;WANG Ke-wei;YAO Yun;HE Zhao-hui
CHEN Hong-xia;WANG Ke-wei;YAO Yun;HE Zhao-hui
..............page:231-233,297
Use of Monte Carlo simulation to optimize vancomycin dosing regimens in MRSA-infected patients with renal dysfunction
WANG Ping1;GAO Xiao-ge1;ZHANG Jian-lei2;XU Yan-gui1
WANG Ping1;GAO Xiao-ge1;ZHANG Jian-lei2;XU Yan-gui1
..............page:335-338
In vitro percutaneous absorption of butenafine hydrochloride cream
LUO Rong;ZHANG Xin-hua;ZHOU Lin;CHEN Wei
LUO Rong;ZHANG Xin-hua;ZHOU Lin;CHEN Wei
..............page:310-314,323
..............page:327-331
Discussion on common problems in writing scientific papers of pharmacy
FU De-xing;JIN Peng-fei;ZHANG Ya-tong;LIU Zhi-jun;HU Xin
FU De-xing;JIN Peng-fei;ZHANG Ya-tong;LIU Zhi-jun;HU Xin
..............page:332-334
Effect of Simiaojunyi ointment on postoperative wound healing in rats
HE Yong-heng;LUO Min
HE Yong-heng;LUO Min
..............page:300-302
Efficacy and safety of calcium polycarbophil in the treatment of constipation-predominant irritable bowel syndrome
YANG Jun1;LI Xi-shi1;FENG Yu-liang1;ZHU Qin1;HAN Zhao-min2; JIN Xiao-qing2;JIN Fu-bi1;DAI Yi-yang1
YANG Jun1;LI Xi-shi1;FENG Yu-liang1;ZHU Qin1;HAN Zhao-min2; JIN Xiao-qing2;JIN Fu-bi1;DAI Yi-yang1
..............page:293-297
..............page:221-222
Process and practical operation of pharmaceutical patent application for invention
MA Xu1;WANG Guo-zhen2;ZHANG Qing-kui2
MA Xu1;WANG Guo-zhen2;ZHANG Qing-kui2
..............page:234-239
Preparation of vinorelbine bitartrate long-circulating liposomes by ionophore A23187-mediated pH gradient method
YANG Guang-li1;2;ZHANG Bing2;ZHAO Li-gang1;2;ZHANG Yong1;2; WANG Dong-hai1;2;YIN Qing2;YANG Qing-min1;2
YANG Guang-li1;2;ZHANG Bing2;ZHAO Li-gang1;2;ZHANG Yong1;2; WANG Dong-hai1;2;YIN Qing2;YANG Qing-min1;2
..............page:251-256
Comparison of the vasorelaxant effects of cyclovirobuxine D and its derivatives in rat aorta rings
SHEN Jun-ling1;2;4;GUO Jia-bin1;GAO Ze-jun3;XU Qi-tai2;PENG Shuang-qing1;2
SHEN Jun-ling1;2;4;GUO Jia-bin1;GAO Ze-jun3;XU Qi-tai2;PENG Shuang-qing1;2
..............page:240-245
Efficacy of rosuvastatin in the treatment of early diabetic nephropathy
LI Rong-fei1;YI Gao-zhong2;LIU Zhi-hua1
LI Rong-fei1;YI Gao-zhong2;LIU Zhi-hua1
..............page:298-299,309
Comparison of efficacies of diammonium glycyrrhizinate and polyene phosphatidylcholine on nonalcoholic steatohepatitis
GUO Xiu-li;LIANG Pi-xia;XU You-qing
GUO Xiu-li;LIANG Pi-xia;XU You-qing
..............page:289-292
Study on angiotensin Ⅱ receptor antagonists as a new type of antihypertensive drug
NIE Yong-yan;LI Fu-min;ZHENG Hao;CHEN Zhi-long
NIE Yong-yan;LI Fu-min;ZHENG Hao;CHEN Zhi-long
..............page:273-282
Discovery of imrecoxib
GUO Zong-ru
GUO Zong-ru
..............page:223-230
Preclinical safety evaluation of pegylated recombinant human granulocyte colony-stimulating factor in rhesus monkey
ZHOU Xiao-bing1;SUN Li1;CHEN Ya-hong2;QU Zhe1;SHEN Lian-zhong1;WANG Yue1; MIAO Yu-fa1;JIANG Hua1;YANG Yan-wei1;LIU Fang1;PAN Dong-sheng1; LI Bao-wen1;WANG Xue1;WANG Xiu-wen1;LI Bo1
ZHOU Xiao-bing1;SUN Li1;CHEN Ya-hong2;QU Zhe1;SHEN Lian-zhong1;WANG Yue1; MIAO Yu-fa1;JIANG Hua1;YANG Yan-wei1;LIU Fang1;PAN Dong-sheng1; LI Bao-wen1;WANG Xue1;WANG Xiu-wen1;LI Bo1
..............page:262-267
Case report of hypersensitivity reactions to carboplatin and pharmacy service
FANG Hong;DAI Yuan-yuan;SHENG Ming-yu;DONG Bin
FANG Hong;DAI Yuan-yuan;SHENG Ming-yu;DONG Bin
..............page:339-342
Protocol deviations in clinical trials of new drug application
ZHU Sai-nan1;YU Yong-pei2;YAN Xiao-yan3;YAO Chen1;3
ZHU Sai-nan1;YU Yong-pei2;YAN Xiao-yan3;YAO Chen1;3
..............page:283-288
Simultaneous determination of three components in the compound spraying agent for chronic pharyngitis by HPLC
WU Yan;ZHANG Fu-cheng;XU Rong;JIN Fang-qing;LIU Yuan;HU Xiang-hua
WU Yan;ZHANG Fu-cheng;XU Rong;JIN Fang-qing;LIU Yuan;HU Xiang-hua
..............page:324-326
Identification of the related substances in tenofovir dipivoxil fumarate with hyphenated techniques
ZHAO Hua;SONG Min;HANG Tai-jun
ZHAO Hua;SONG Min;HANG Tai-jun
..............page:318-323